ArticleNeurology. Clinical practice2025

Dissemination of VMAT-2 Inhibitors: A New Class Drug for Tardive Dyskinesia and Huntington Disease.

Erica Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.